Cargando…

5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabine

Capecitabine is selectively converted from 5′-DFUR to 5-fluorouracil (5-FU) in tumours by thymidine phosphorylase (TP). We investigated the addition of 5-nitrouracil (5-NU), a TP inhibitor, into blood samples for precise measurements of plasma 5-FU concentrations. The plasma concentration of 5-FU wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Yoichiro, Hashimoto, Yasuhiro, Miyazaki, Makoto, Aisu, Naoya, Yamada, Teppei, Kajitani, Ryuji, Munechika, Taro, Matsumoto, Yoshiko, Nagano, Hideki, Shimaoka, Hideki, Komono, Akira, Sakamoto, Ryohei, Yoshimatsu, Gumpei, Yoshimura, Fumihiro, Kiyomi, Fumiaki, Hasegawa, Suguru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026090/ https://www.ncbi.nlm.nih.gov/pubmed/32066801 http://dx.doi.org/10.1038/s41598-020-59648-2

Ejemplares similares

Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer
por: Hayashi, Takaomi, et al.
Publicado: (2022)

Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancer
por: Tanaka, Keita, et al.
Publicado: (2021)

Reconstruction with omental flap and negative pressure wound therapy after total pelvic exenteration of anal fistula cancer: a case report
por: Komono, Akira, et al.
Publicado: (2022)

Detection of carbon dioxide embolism by transesophageal echocardiography during transanal/perineal endoscopic surgery: a pilot study
por: Matsumoto, Yoshiko, et al.
Publicado: (2022)

Evaluation of vascular pain in patients with colorectal cancer receiving peripheral venous chemotherapy with or without oxaliplatin
por: Matsuoka, Taisuke, et al.
Publicado: (2019)

Combined laparoscopic and transperineal endoscopic total pelvic exenteration for the vaginal stump recurrence of cervical cancer
por: Ohno, Ryo, et al.
Publicado: (2021)

Transanal TME: new standard or fad?
por: Hasegawa, Suguru, et al.
Publicado: (2019)

The Relationship Between Evaluation Methods for Chemotherapy-Induced Peripheral Neuropathy
por: Yoshida, Yoichiro, et al.
Publicado: (2019)

Two case of bilateral approach in laparoscopic pancreas-sparing distal duodenectomy for duodenal neoplasms arising from the distal duodenum
por: Nagano, Hideki, et al.
Publicado: (2021)

A new polymorph of 5-nitrouracil monohydrate
por: Pereira Silva, P. S., et al.
Publicado: (2008)

Phase 2 study of perioperative chemotherapy with SOX and surgery for stage III colorectal cancer (SOS3 study)
por: Aisu, Naoya, et al.
Publicado: (2019)

Hydrogen bonding patterns in the cocrystals of 5-nitrouracil with several donor and acceptor molecules
por: Thomas, Reji, et al.
Publicado: (2005)

A Case of Posterior Interosseous Nerve Palsy Associated With Robotic Low Anterior Resection
por: Ohno, Ryo, et al.
Publicado: (2023)

Difference in Neutropenia due to Administration Schedule of TAS-102
por: Yoshida, Yoichiro, et al.
Publicado: (2017)

Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports
por: Brickell, K, et al.
Publicado: (2003)

Phase II study on early start of chemotherapy after excising primary colorectal cancer with distant metastases (Pearl Star 02)
por: Yoshida, Yoichiro, et al.
Publicado: (2017)

Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death
por: Matsuoka, Taisuke, et al.
Publicado: (2020)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

Solid-phase molecular recognition of cytosine based on proton-transfer reaction. Part II. supramolecular architecture in the cocrystals of cytosine and its 5-Fluoroderivative with 5-Nitrouracil
por: Portalone, Gustavo
Publicado: (2011)

Comparison of the Efficacy of Oral Capecitabine versus Bolus 5-FU in Preoperative Radiotherapy of Locally Advanced Rectal Cancer
por: Kim, Jae-Sung, et al.
Publicado: (2006)

A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients
por: Chen, Qi, et al.
Publicado: (2017)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

Objective evaluation of oxaliplatin-induced vascular pain secondary to peripheral vein administration
por: Yoshida, Yoichiro, et al.
Publicado: (2016)

A case of endoscopic full‐thickness resection for gastric gastrointestinal stromal tumor in the submucosal tunnel
por: Shiwaku, Hironari, et al.
Publicado: (2023)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
por: Cassidy, J, et al.
Publicado: (2006)

γ-tocotrienol prevents 5-FU-induced reactive oxygen species production in human oral keratinocytes through the stabilization of 5-FU-induced activation of Nrf2
por: TAKANO, HIDEYUKI, et al.
Publicado: (2015)

Endoscopic ligation technique for refractory gastrotracheal fistula
por: Shiwaku, Hironari, et al.
Publicado: (2023)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

Trans-anal Minimally Invasive Surgery Combined With a Robotic Anterior Approach for Sleeve Resection of a Huge Rectal Gastrointestinal Stromal Tumor
por: Kojima, Daibo, et al.
Publicado: (2023)

Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus
por: Takahashi, Hiroyuki, et al.
Publicado: (2019)

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.
por: Fleming, R. A., et al.
Publicado: (1992)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
por: De Angelis, Paula M, et al.
Publicado: (2006)

5-FU toxicity and nutritional deficiencies.
por: Stenram, U.
Publicado: (1993)

Fluorouracil (5-FU)-induced Cardiomyopathy
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
por: Dolat, Marine, et al.
Publicado: (2020)

Endoscopic full‐thickness resection of an esophageal leiomyoma located in close proximity to the azygos vein
por: Shiwaku, Hironari, et al.
Publicado: (2021)

Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
por: Yoshida, Yoichiro, et al.
Publicado: (2015)

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
por: Anaka, Matthew, et al.
Publicado: (2022)

Whole transcriptome sequence data of 5-FU sensitive and 5-FU resistant tumors generated in a mouse model of de novo carcinogenesis
por: Iacovides, Demetris, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9661ih5pe70d4tbmfh2furuqrj